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Uterine leiomyomas are benign tumors that occur in
about 20–25% of women in their reproductive years.
Submucous myomas may present a greater risk to the
patient than either intramural or subserous varieties,
because they cause heavy uterine bleeding and dysmen-
orrhea, and interfere with normal reproduction.
A transcervical approach is minimally invasive for
myomectomy, and hysteroscopic myomectomy is the
best treatment for women with submucous leiomyomas
[1]. However, not all submucous leiomyomas can be
easily treated by hysteroresectoscopy. Although hystero-
scopic resection of a pedunculated submucous leiomy-
oma is not difficult, myomas that are partly or mostly
intramural increase the risk of uterine perforation or
incomplete excision [2].
A 43-year-old single woman had experienced heavy
menstrual flow for about 7 months. Her condition was
complicated with anemia (hemoglobin 9.6 g/dL), which
caused her to feel dizzy. She had tried herbal medicine
for 6 months, but the menorrhagia worsened. She came
to our gynecology outpatient department in October
2006. Gynecologic ultrasound revealed a leiomyoma of
42 × 36 × 41 mm in the central part of the uterus
(Figure 1), so a submucous myoma was highly suspected.
We arranged hysteroscopy for diagnosis and treatment
of the menorrhagia in the early proliferative phase of
the menstrual cycle. After insertion of the resectoscope,
the submucous myoma could hardly be identified simply
under hysteroscopy. Using an ultrasound monitor, we
located the sinking submucous myoma on the right ante-
rior wall of the uterus. Obviously, the myoma presented
in this patient was type II (> 50% contained within the
myometrium) according to the European Society for
Gynecologic Endoscopy classification of submucous
fibroids (Figure 2). Hysteroscopic myomectomy was
performed under the guidance of a bipolar intrauterine
system (Versapoint; Ethicon Inc., Somerville, NJ, USA)
with 0.9% normal saline as distension medium. The
procedure involved first cutting open the central portion
of the myoma to identify the myoma and myometrial
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Myoma
Figure 1. Two-dimensional transabdominal ultrasonography
reveals a globular uterus with a leiomyoma measuring 42 ×
36 × 41 mm, located in the central part of the uterus.
Sinking submucous myoma
Figure 2. The submucous myoma can hardly be identified
initially using hysteroscopy.
Taiwan J Obstet Gynecol • June 2008 • Vol 47 • No 2 239
Hysteroscopic Removal of Large Sinking Submucous Myoma
junction (Figure 3), and shaving the myoma. Then, the
myoma was dissected from the muscular layer using the
tip of the resectoscope via repeated sudden removal of
the resectoscope to produce a rebound effect in decreas-
ing intrauterine pressure. It gradually pulled the myoma
further into the intrauterine cavity (Figure 4). Complete
resectoscopic removal of the submucous myoma was
achieved using the above technique. No fluid overload
syndrome developed. The patient tolerated the whole
procedure well and was discharged the next day. Ultra-
sonography revealed no residual myoma in this patient
at the follow-up 2 weeks after surgery. After 9 months
of follow-up, the patient was satisfied with the operation
results, especially regarding menorrhagia control. No
myoma recurrence was noted at a recent ultrasono-
graphic examination.
Myomas with the greatest diameter within the uterine
wall have been associated with increased operating time
and potential side effects, such as heavy hemorrhage,
difficulty to control uterine perforation and water intox-
ication, and often require a second-stage operation to
remove the myoma when the remaining portion of the
submucous fibroid has been pushed into the uterine
cavity by continuous myometrial contraction [3].
There has been evidence of the efficacy of preoper-
ative medical treatment with gonadotropin-releasing
hormone (GnRH) agonists in facilitating surgery and
improving the long-term result of hysteroscopic myo-
mectomy [3]. In a review of several randomized and
nonrandomized control clinical trials published in the
English literature between 1990 and 1996, studies com-
paring the use of GnRH agonists and no prior treatment
have shown that preoperative treatment reduced fluid
absorption during surgery, ranging from 142 to 572 mL
[4]. A decrease in operation time (between 2 and 25
minutes) was also observed in GnRH agonist-treated
groups in comparison with untreated controls [4].
Successful outcome depends not only on operative
skill but also on the guidance under sonogram. To pre-
vent uterine perforation during removal of deep infil-
trating submucous myomas, the myometrial thickness
between the myoma and serosa is checked before oper-
ation. The thickness increases gradually during operation
as a result of uterine contraction. According to the ex-
perience of Yang and Lin [5], it is safe even when the
myometrial thickness at the implantation site is as thin
as 5 mm.
Several techniques have been reported for hystero-
scopic myomectomy of sessile submucous leiomyomas,
including: (1) a two-step procedure combined with
GnRH agonist therapy [6], (2) a one-step myomec-
tomy with a two-resectoscope method [7] or a maneuver
using digital pressure [8], (3) intraoperative injection
of an oxytocic agent, prostaglandin F2α to myometrium
under laparoscopically, and (4) shaving the intramural
component, whereby the uterine wall contracts and
pushes the intramural portion into the uterine cavity,
permitting the complete resection of myoma, if the
intramural portion does not involve the entire uterine
wall [9].
Two important anatomic landmarks can assist the
hysteroscopist in the removal of submucous leiomy-
omas: (1) the consistency and texture of the fibrous
tissue of the myoma are determined by gently touching
the tissue with the inactivated loop, permitting the
pseudocapsule to be easily felt; and (2) when the resec-
tion comes in contact with the juxtaposed myometrium,
the fascicular myometrial tissue can be easily contrasted
with the fibrous myomatous tissue. In addition, the
Myoma
Myometrial, 
uterine wall
Figure 3. The junctional zone between myoma and uterine
wall is clearly defined after cutting the central portion of 
the myoma and several passes of the electrode.
Myoma
Figure 4. Hysteroscopic appearance of the intramural portion
of the submucous myoma protruding further into the uterine
cavity after the electrode has shaved through the myoma.
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softness of the muscular tissue can be palpated with the
inactivated loop, signaling the termination of resection.
To reduce the need for reintervention, appropriate
patient selection and improved techniques are neces-
sary. Our treatment approach has been proven to be
safe and efficient for removal of a huge sinking submu-
cous myoma in a one-step hysteroscopic procedure.
Concurrent ultrasonography is vital in the initial resec-
tion. The uterine walls, myoma and resectoscope are
all clearly seen with the aid of ultrasound, which
enables a safe hysteroscopic operation.
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